Healthcare Cost, BIDMC and Strategy
A recent posting by Paul Levy, CEO, Beth Israel Deaconess Medical Center (BIDMC), Boston, on his blog asked some questions about strategic planning that I, and an enthusiastic number of others, responded to. (Note to self: remember to better identify yourself, BLOG Medicine, or Maynard & Company, Inc., as appropriate, when commenting in blogs.)
What had prompted Paul's question was a recent post by Charlie Baker, President and CEO, Harvard Pilgrim Healthcare on his blog that would seem to reinforce the idea that payors reimburse based on market power rather than quality clinical outcomes. A number of respondents, in their own way, mirror or support my own response, including, interestingly, that of Andrew Dreyfus, Blue Cross Blue Shield of Massachusetts.
Regardless of what payors may say, market power currently drives reimbursement and hospitals should plan accordingly. Evolution of reimbursement methodologies that incorporates quality initiatives and healthcare transparency can be seen, but this change is slow and seemingly made only grudgingly. Strategic plans, however, are a dynamic document and BIDMC can effectively incorporate none, some, or all of the suggested responses to increasing healthcare costs, decreasing revenue, and questionable clinical outcome reporting knowing that the plan will change again a year from now.■
Recent Comments